Relafen 750, structurally known as its salt form, offers a distinct physiological pathway of action. From a pharmaceutical standpoint , it functions primarily as a NSAID compound , inhibiting cyclooxygenase enzymes – specifically COX-1 and COX-2 – to alleviate pain and fever . The subsequent decrease in inflammatory mediator production impacts